(Total Views: 276)
Posted On: 01/16/2019 1:36:06 PM
Post# of 36519
My thoughts exactly. I am expecting GNBT to trade well above where it is now.
Imho, the sky is the limit as long as the company executes under Mr Joe Moscato. He has a vision and seems to have an excellent group of people helping him doing the research and planning for where he wants to take Generex. This is a major undertaking.
Fuse Medical ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500T.
"During the selected period, Fuse’s revenue grew 2,706% securing the No. 56 spot on the list. Overall, 2018 Technology Fast 500TM, companies achieved revenue growth ranging from 143% to 77,260% percent, with the medical device sector having median growth at 396% percent. "
https://www.businesswire.com/news/home/201811...st-Growing
Imho, the sky is the limit as long as the company executes under Mr Joe Moscato. He has a vision and seems to have an excellent group of people helping him doing the research and planning for where he wants to take Generex. This is a major undertaking.
Fuse Medical ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500T.
"During the selected period, Fuse’s revenue grew 2,706% securing the No. 56 spot on the list. Overall, 2018 Technology Fast 500TM, companies achieved revenue growth ranging from 143% to 77,260% percent, with the medical device sector having median growth at 396% percent. "
https://www.businesswire.com/news/home/201811...st-Growing
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)